Trans-delta-9-tetrahydrocannabinol: effects on macromolecular content of mouse liver tissue
Baker, B.; Rogers, S.
Research Communications in Chemical Pathology and Pharmacology 21(3): 569-572
1978
ISSN/ISBN: 0034-5164 PMID: 705030 Document Number: 135011
Mice were starved for 72 hours then injected with a total of 50 mg/kg THC over 48 hours during which time the animals were fed ad libitum. At the end of the 48 hours, the mice were sacrificed and the livers were analyzed quantitatively for DNA, RNA, protein, and glycogen. It was determined that the THC had no effect on the DNA or glycogen levels. The amount of RNA increased significantly when compared to controls while protein levels decreased by 50%.
Document emailed within 1 workday
Related Documents
Watanabe, K.; Hirahashi, N.; Narimatsu, S.; Yamamoto, I.; Yoshimura, H. 1991: Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(1): 218-221McMillan, D.E.; Harris, L.S.; Frankenheim, J.M.; Kennedy, J.S. 1970: L-delta-9-trans-tetrahydrocannabinol in pigeons: tolerance to the behavioral effects Science 169(3944): 501-503
Watanabe, K.; Yamamoto, I.; Oguri, K.; Yoshimura, H. 1981: Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice Drug Metabolism and Disposition: the Biological Fate of Chemicals 9(3): 261-264
Zimmer, B.D.; Bickel, P.; Dittrich, A. 1976: Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication Arzneimittel-Forschung 26(8): 1614-1616
Leighty, E.G. 1979: Hydrolysis of 11-palmitoyloxy-delta 9-tetrahydrocannabinol to 11-hydroxy-delta 9-tetrahydrocannabinol by cholesterol esterase and a lipase Research Communications in Chemical Pathology and Pharmacology 24(2): 393-396
McMillan, D.E.; Leander, J.D.; Dudley, K.H. 1980: Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol Journal of Pharmacology and Experimental Therapeutics 212(1): 85-90
Sklenovský, A.; Navrátil, J.; Hrbek, J.; Chmela, Z.; Krejcí, Z. 1976: The effect of delta-9-tetrahydrocannabinol (delta-9-THC) upon the release of unesterified fatty acids in the brain Acta Universitatis Palackianae Olomucensis Facultatis Medicae 80: 183-188
Lindamood, C.; Colasanti, B.K. 1980: Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus Journal of Pharmacology and Experimental Therapeutics 213(2): 216-221
Kanter, S.L.; Musumeci, M.R.; Hollister, L.E. 1979: Quantitative determination of delta 9-tetrahydrocannabinol and delta 9-tetrahydro-cannabinolic acid in marihuana by high-pressure liquid chromatography Journal of Chromatography 171: 504-508
Hillard, C.J.; Pounds, J.J.; Boyer, D.R.; Bloom, A.S. 1990: Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart Journal of Pharmacology and Experimental Therapeutics 252(3): 1075-1082
Field, E.; Tyrey, L. 1986: Tolerance to the luteinizing hormone and prolactin suppressive effects of delta-9-tetrahydrocannabinol develops during chronic prepubertal treatment of female rats Journal of Pharmacology and Experimental Therapeutics 238(3): 1034-1038
Matsumoto, K.; Tsuda, T.; Sakai, T.; Tsuboshima, M. 1982: Effects of 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (ONO-802) on reproductive function Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 79(1): 15-22
Zaremba, S.; Gwóźdź, H.; Banach, M. 1987: Effect of lectin from Phaseolus vulgaris (PHA-M) on the glucose content in the blood and the content of glycogen in the mouse liver and muscles Folia Biologica 35(1-2): 3-12
Fang, L.; Knapp, R.J.; Horvath, R.; Matsunaga, T.O.; Haaseth, R.C.; Hruby, V.J.; Porreca, F.; Yamamura, H.I. 1994: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity Journal of Pharmacology and Experimental Therapeutics 268(2): 836-846
Matsunaga, T.; Kishi, N.; Tanaka, H.; Watanabe, K.; Yoshimura, H.; Yamamoto, I. 1998: Major cytochrome P450 enzyme responsible for oxidation of secondary alcohols to the corresponding ketones in mouse hepatic microsomes. Oxidation of 7-hydroxy-delta8-tetrahydrocannabinol to 7-oxo-delta8-tetrahydrocannabinol Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(10): 1045-1047
Nahas, G.G.; Schwartz, I.; Palacek, I.; Tannières, M.L. 1972: Delta 9-tetrahydrocannabinol tolerance in the familial hypertensive rat Journal de Physiologie 65(Suppl 3): 461a
Ono, M.; Shimamine, M.; Takahashi, K.; Inoue, T. 1974: Studies on hallucinogens. Vi Synthesis of delta-6a,10a-tetrahydrocannabinol Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 49(92): 44-46
Rizzetto, M.; Shih, J.W.; Gerin, J.L. 1980: The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen Journal of Immunology 125(1): 318-324
Smith, P.B.; Welch, S.P.; Martin, B.R. 1994: Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice Journal of Pharmacology and Experimental Therapeutics 268(3): 1381-1387
Bachmann, E.W.; Hofmann, A.A.; Waser, P.G. 1979: Identification of delta 9-tetrahydrocannabinol in human plasma by gas chromatography Journal of Chromatography 178(1): 320-323